Literature DB >> 8931464

Regulation of GABA level in rat brain synaptosomes: fluxes through enzymes of the GABA shunt and effects of glutamate, calcium, and ketone bodies.

M Erecińska1, D Nelson, Y Daikhin, M Yudkoff.   

Abstract

Stable isotopes were used to measure both the rate of GABA formation by glutamic acid decarboxylase (GAD) and the rate of utilization by GABA-transaminase (GABA-T). The initial rate of GABA accumulation, determined with either [2-15N]glutamine or [2H5]glutamine as precursor, was 0.3-0.4 nmol/min/mg of protein. Addition of the calcium ionophore A23187 enhanced GAD activity, whereas changes in levels of inorganic phosphate and H+ were without influence. Flux through GABA-T (GABA--> glutamate), measured with [15N]GABA as precursor, was 0.82 nmol/min/mg of protein, whereas the reamination of succinic acid semialdehyde (reverse flux through GABA-T) was almost sixfold faster, 4.8 nmol/min/mg of protein. The rate of GABA metabolism via the tricarboxylic acid cycle was very slow, with the upper limit on flux being 0.03 nmol/min/mg of protein. Addition of either acetoacetate or beta-hydroxybutyrate raised the internal content of glutamate and reduced that of aspartate; the GABA concentration and the rate of its formation increased. It is concluded that in synaptosomes (a) GABA-T is a primary factor in regulating the turnover of GABA, (b) a major regulator of GAD activity is the concentration of internal calcium, (c) GAD in nerve endings may not be saturated with its substrate, glutamate, and the concentration of the latter is a determinant of flux through this pathway, and (d) levels of ketone bodies increase, and maintain at a higher value, the synaptosomal content of GABA, a phenomenon that may contribute to the beneficial effect of a ketogenic diet in the treatment of epilepsy.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8931464     DOI: 10.1046/j.1471-4159.1996.67062325.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  43 in total

Review 1.  Ketone bodies in epilepsy.

Authors:  Melanie A McNally; Adam L Hartman
Journal:  J Neurochem       Date:  2012-02-07       Impact factor: 5.372

2.  Contribution of L-type channels to Ca2+ regulation of neuronal properties in early developing purkinje neurons.

Authors:  D L Gruol; J G Netzeband; L A Quina; P K Blakely-Gonzalez
Journal:  Cerebellum       Date:  2005       Impact factor: 3.847

Review 3.  Neuroprotective and disease-modifying effects of the ketogenic diet.

Authors:  Maciej Gasior; Michael A Rogawski; Adam L Hartman
Journal:  Behav Pharmacol       Date:  2006-09       Impact factor: 2.293

Review 4.  The ketogenic diet in a pill: is this possible?

Authors:  Jong M Rho; Raman Sankar
Journal:  Epilepsia       Date:  2008-11       Impact factor: 5.864

Review 5.  Mitochondrial energetics and therapeutics.

Authors:  Douglas C Wallace; Weiwei Fan; Vincent Procaccio
Journal:  Annu Rev Pathol       Date:  2010       Impact factor: 23.472

Review 6.  Are therapeutic diets an emerging additional choice in autism spectrum disorder management?

Authors:  M Gogou; G Kolios
Journal:  World J Pediatr       Date:  2018-05-30       Impact factor: 2.764

7.  A ketone ester diet increases brain malonyl-CoA and Uncoupling proteins 4 and 5 while decreasing food intake in the normal Wistar Rat.

Authors:  Yoshihiro Kashiwaya; Robert Pawlosky; William Markis; M Todd King; Christian Bergman; Shireesh Srivastava; Andrew Murray; Kieran Clarke; Richard L Veech
Journal:  J Biol Chem       Date:  2010-06-07       Impact factor: 5.157

Review 8.  β-Hydroxybutyrate in the Brain: One Molecule, Multiple Mechanisms.

Authors:  Lavanya B Achanta; Caroline D Rae
Journal:  Neurochem Res       Date:  2016-11-08       Impact factor: 3.996

Review 9.  Progress in neuroprotective strategies for preventing epilepsy.

Authors:  Munjal M Acharya; Bharathi Hattiangady; Ashok K Shetty
Journal:  Prog Neurobiol       Date:  2007-12-08       Impact factor: 11.685

Review 10.  Ketosis and brain handling of glutamate, glutamine, and GABA.

Authors:  Marc Yudkoff; Yevgeny Daikhin; Oksana Horyn; Ilana Nissim; Itzhak Nissim
Journal:  Epilepsia       Date:  2008-11       Impact factor: 5.864

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.